Year: 2013
Type: article
Study design: Observational Study
Abstract: A recent genome-wide association study identified hepatocyte nuclear factor 1-α (HNF1A) as a key regulator of fucosylation. We hypothesized that loss-of-function HNF1A mutations causal for maturity-onset diabetes of the young (MODY) would display altered fucosylation of N-linked glycans on plasma proteins and that glycan biomarkers could improve the efficiency of a diagnosis of HNF1A-MODY. In a pilot comparison of 33 subjects with HNF1A-MODY and 41 subjects with type 2 diabetes, 15 of 29 glycan measurements differed between the two groups. The DG9-glycan index, which is the ratio of fucosylated to nonfucosylated triantennary glycans, provided optimum discrimination in the pilot study and was examined further among additional subjects with HNF1A-MODY (n = 188), glucokinase (GCK)-MODY (n = 118), hepatocyte nuclear factor 4-α (HNF4A)-MODY (n = 40), type 1 diabetes (n = 98), type 2 diabetes (n = 167), and nondiabetic controls (n = 98). The DG9-glycan index was markedly lower in HNF1A-MODY than in controls or other diabetes subtypes, offered good discrimination between HNF1A-MODY and both type 1 and type 2 diabetes (C statistic ≥ 0.90), and enabled us to detect three previously undetected HNF1A mutations in patients with diabetes. In conclusion, glycan profiles are altered substantially in HNF1A-MODY, and the DG9-glycan index has potential clinical value as a diagnostic biomarker of HNF1A dysfunction.
Source: Diabetes
DOI: 10.2337/db12-0880
Authors: Gaya Thanabalasingham, Jennifer E. Huffman, Jayesh J. Kattla, Mislav Novokmet, Igor Rudan, Anna L. Gloyn, Caroline Hayward, Barbara Adamczyk, Rebecca M. Reynolds, Ana Muzinic, Neelam Hassanali, Maja Pucic, Amanda J. Bennett, Abdelkader Essafi, Ozren Polasek, Saima A. Mughal, Irma Redzic, Dragan Primorac, Lina Zgaga, Ivana Kolcic, Torben Hansen, Daniela Gasperikova, Erling Tjora, Mark W.J. Strachan, Trine Nielsen, Juraj Stanik, Iwar Klimes, Oluf B. Pedersen, Pål R. Njølstad, Sarah H. Wild, Ulf Gyllensten, Olga Gornik, James F. Wilson, Nicholas D. Hastie, Harry Campbell, Mark I. McCarthy, Pauline M. Rudd, Katharine R. Owen, Gordan Lauc, Alan F. Wright
Institutions: Churchill Hospital, University of Oxford, NIHR Oxford Biomedical Research Centre, Oxford Centre for Diabetes, Endocrinology and Metabolism, Institute of Genetics and Cancer, MRC Human Genetics Unit, University of Edinburgh, National Institute for Bioprocessing Research and Training, Genos (Croatia), University of Split, The Queen's Medical Research Institute, University of Zagreb, University of Osijek, University of Copenhagen, University of Southern Denmark, Novo Nordisk Foundation Center for Basic Metabolic Research, Slovak Academy of Sciences, Institute of Experimental Endocrinology of the Slovak Academy of Sciences, Haukeland University Hospital, University of Bergen, Western General Hospital, Comenius University Bratislava, Aarhus University, Uppsala University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Funders: Wellcome Trust, Scottish Government, National Institute for Health and Care Research, European Commission, Lundbeckfonden, Helse Vest, Hrvatska Zaklada za Znanost, Universitetet i Bergen, Norges Forskningsråd, H. Lundbeck A/S, Diabetesforeningen, Medical Research Council, European Regional Development Fund, National Heart, Lung, and Blood Institute
Awards: Comprehensive Sequencing and Analysis of Variation in NHLBI Cohorts, Northwest Genomics Center, Bridging the gap from type 2 diabetes genetics to functional mechanisms of disease., ARRA - NHLBI Lung Cohorts Sequencing Project, WHI Sequencing Project (WHISP), Comprehensive Sequencing and Analysis of Variation in NHLBI Cohorts, ARRA - NHLBI Lung Cohorts Sequencing Project, Human Exome Sequencing in Six Well-Phenotyped NHLBI Cohorts, NIHR Senior Investigator Award, Human Exome Sequencing in Six Well-Phenotyped NHLBI Cohorts, WHI Sequencing Project (WHISP), Northwest Genomics Center, Understanding the genetic basis of common human diseases: core funding for the Wellcome Trust Centre for Human Genetics., Translating Genetic and Molecular Phenotyping in Diabetes into Clinical Care
OpenAlex ID: W2143431207
